These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27813696)

  • 21. Tracheobronchial anomalies in a patient with Schimke immuno-osseous dysplasia (SIOD).
    Mobeireek A; Saleemi S; Khalid M; Imtiaz F; Almutairy EA
    Am J Med Genet A; 2015 Feb; 167A(2):434-7. PubMed ID: 25428399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated multiplex ligation dependent probe amplification (MLPA) assays for the detection of alterations in the HEXB, GM2A and SMARCAL1 genes to support the diagnosis of Morbus Sandhoff, M. Tay-Sachs variant AB and Schimke immuno-osseous dysplasia in humans.
    Sobek AK; Evers C; Dekomien G
    Mol Cell Probes; 2013 Feb; 27(1):32-7. PubMed ID: 23010210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schimke immuno-osseous dysplasia: a cell autonomous disorder?
    Elizondo LI; Huang C; Northrop JL; Deguchi K; Clewing JM; Armstrong DL; Boerkoel CF
    Am J Med Genet A; 2006 Feb; 140(4):340-8. PubMed ID: 16419127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMARCAL1, the annealing helicase and the transcriptional co-regulator.
    Bansal R; Hussain S; Chanana UB; Bisht D; Goel I; Muthuswami R
    IUBMB Life; 2020 Oct; 72(10):2080-2096. PubMed ID: 32754981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocytic infolding in Schimke immuno-osseous dysplasia with novel SMARCAL1 mutations: a case report.
    Xiong S; Shuai L; Li X; Dang X; Wu X; He Q
    BMC Nephrol; 2020 May; 21(1):170. PubMed ID: 32393263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A patient with Silver-Russell syndrome with multilocus imprinting disturbance, and Schimke immuno-osseous dysplasia unmasked by uniparental isodisomy of chromosome 2.
    Hara-Isono K; Matsubara K; Hamada R; Shimada S; Yamaguchi T; Wakui K; Miyazaki O; Muroya K; Kurosawa K; Fukami M; Ogata T; Kosho T; Kagami M
    J Hum Genet; 2021 Nov; 66(11):1121-1126. PubMed ID: 34031513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schimke immuno-osseous dysplasia, two new cases with peculiar EEG pattern.
    Prato G; De Grandis E; Mancardi MM; Cordani R; Giacomini T; Pisciotta L; Uccella S; Severino M; Tortora D; Pavanello M; Bertamino M; Verrina E; Caridi G; Di Rocco M; Nobili L
    Brain Dev; 2020 May; 42(5):408-413. PubMed ID: 32115305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.
    Bökenkamp A; deJong M; van Wijk JA; Block D; van Hagen JM; Ludwig M
    Pediatr Nephrol; 2005 Dec; 20(12):1724-8. PubMed ID: 16237566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel compound heterozygous variant in
    Wang L; Li J; Wu G; Kong X
    J Int Med Res; 2021 Apr; 49(4):3000605211010644. PubMed ID: 33900868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel compound mutations of SMARCAL1 associated with severe Schimke immuno-osseous dysplasia in a Chinese patient.
    Yue Z; Xiong S; Sun L; Huang W; Mo Y; Huang L; Jiang X; Chen S; Hu B; Wang Y
    Nephrol Dial Transplant; 2010 May; 25(5):1697-702. PubMed ID: 20179009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia.
    Boerkoel CF; Takashima H; John J; Yan J; Stankiewicz P; Rosenbarker L; André JL; Bogdanovic R; Burguet A; Cockfield S; Cordeiro I; Fründ S; Illies F; Joseph M; Kaitila I; Lama G; Loirat C; McLeod DR; Milford DV; Petty EM; Rodrigo F; Saraiva JM; Schmidt B; Smith GC; Spranger J; Stein A; Thiele H; Tizard J; Weksberg R; Lupski JR; Stockton DW
    Nat Genet; 2002 Feb; 30(2):215-20. PubMed ID: 11799392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Phenotypes of Schimke Immuno-Osseous Dysplasia (SIOD) in Two Sisters with the Same Mutation in the SMARCAL1 Gene.
    Castellano-Martinez A; Acuñas-Soto S; Varga-Martinez R; Rodriguez-Gonzalez M; Mora-Lopez F; Iriarte-Gahete M; Roldan-Cano V
    Endocr Metab Immune Disord Drug Targets; 2022; 22(8):888-894. PubMed ID: 35209826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells.
    Bertulli C; Marzollo A; Doria M; Di Cesare S; La Scola C; Mencarelli F; Pasini A; Affinita MC; Vidal E; Magini P; Dimartino P; Masetti R; Greco L; Palomba P; Conti F; Pession A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dental abnormalities and preventive oral care in Schimke immuno-osseous dysplasia.
    Gendronneau M; Kérourédan O; Taque S; Sixou JL; Bonnaure-Mallet M
    Eur Arch Paediatr Dent; 2014 Jun; 15(3):217-21. PubMed ID: 24327104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic phenotype of Schimke immuno-osseous dysplasia and neurodevelopmental expression of SMARCAL1.
    Deguchi K; Clewing JM; Elizondo LI; Hirano R; Huang C; Choi K; Sloan EA; Lücke T; Marwedel KM; Powell RD; Santa Cruz K; Willaime-Morawek S; Inoue K; Lou S; Northrop JL; Kanemura Y; van der Kooy D; Okano H; Armstrong DL; Boerkoel CF
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):565-77. PubMed ID: 18520775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schimke immune-osseous dysplasia: A case report.
    Bakr A; Eid R; Sarhan A; Hammad A; El-Refaey AM; El-Mougy A; Zedan MM; ElHusseini F
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):987-91. PubMed ID: 26354575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent.
    Marin AV; Jiménez-Reinoso A; Mazariegos MS; Román-Ortiz E; Regueiro JR
    Front Immunol; 2022; 13():979722. PubMed ID: 36330520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schimke versus non-Schimke chronic kidney disease: an anthropometric approach.
    Lücke T; Franke D; Clewing JM; Boerkoel CF; Ehrich JH; Das AM; Zivicnjak M
    Pediatrics; 2006 Aug; 118(2):e400-7. PubMed ID: 16816006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schimke immunoosseous dysplasia and management considerations for vascular risks.
    Beleford DT; Diab M; Qubty WF; Malloy MJ; Long RK; Shieh JT
    Am J Med Genet A; 2019 Jul; 179(7):1246-1252. PubMed ID: 31039288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schimke immunoosseous dysplasia: suggestions of genetic diversity.
    Clewing JM; Fryssira H; Goodman D; Smithson SF; Sloan EA; Lou S; Huang Y; Choi K; Lücke T; Alpay H; André JL; Asakura Y; Biebuyck-Gouge N; Bogdanovic R; Bonneau D; Cancrini C; Cochat P; Cockfield S; Collard L; Cordeiro I; Cormier-Daire V; Cransberg K; Cutka K; Deschenes G; Ehrich JH; Fründ S; Georgaki H; Guillen-Navarro E; Hinkelmann B; Kanariou M; Kasap B; Kilic SS; Lama G; Lamfers P; Loirat C; Majore S; Milford D; Morin D; Ozdemir N; Pontz BF; Proesmans W; Psoni S; Reichenbach H; Reif S; Rusu C; Saraiva JM; Sakallioglu O; Schmidt B; Shoemaker L; Sigaudy S; Smith G; Sotsiou F; Stajic N; Stein A; Stray-Pedersen A; Taha D; Taque S; Tizard J; Tsimaratos M; Wong NA; Boerkoel CF
    Hum Mutat; 2007 Mar; 28(3):273-83. PubMed ID: 17089404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.